Coherent Market Insights released on December 13, 2021

The main focus of animal health is to provide effective animal health services through the diagnosis and treatment of diseases. The outbreak of animal diseases will lead to strict restrictions on the trade of animal products, thereby increasing the cost of disease management and hampering the European economy.

Request a PDF manual of the latest insights here @ https://www.coherentmarketinsights.com/insight/request-pdf/550

The size of the European animal health market in 2020 is estimated to be USD 13.119 billion, and the compound annual growth rate is expected to be 4.5% during the forecast period (2020-2027).

During the forecast period, the increasing incidence of zoonotic virus pathogens and the continuous expansion of strategies adopted by manufacturers are expected to drive the growth of the European animal health market.

Major companies focus on product launches and collaborative activities to meet the growing demand for animal health. According to the Animal Disease Notification System (ADNS) in 2018, from August 2018 to November 2018, approximately 14 outbreaks of A (H5N8) virus and highly pathogenic avian influenza (HPAI) in poultry were reported in Bulgaria . Therefore, regional government authorities are focusing on improving animal health through cooperation with manufacturers to support R&D activities for the development of new drugs. For example, in July 2019, Ceva Santé Animale acquired the veterinary biopharmaceutical product portfolio of IDT Biologika GmbH, which is expected to strengthen Ceva's product supply.

In addition, European local and regional government authorities are increasingly implementing regulatory policies to improve animal health, which is expected to promote the growth of the European animal health market during the forecast period. For example, in 2018, the European Medicines Agency launched a multi-stakeholder seminar to provide guidelines for veterinary regulatory science and make recommendations for the development of veterinary medicine.

It is expected that during the forecast period, increased preference for animal breeding will drive the growth of the European animal health market.

The animal breeding industry throughout Europe has increased and there is a high demand for effective animal health services to improve food safety. According to a report released by the United States Department of Agriculture (USDA) in 2018, Lithuania is the largest poultry producer among the Baltic countries in Europe. In 2015, Lithuania’s chicken production was approximately 110,700 tons, an increase of 11% year-on-year since 2014.

More and more regulations on animal vaccination have given birth to animal health products, which are expected to promote the growth of the European animal health market in the near future. For example, the European Committee for the Control of Foot-and-Mouth Disease (EuFMD) and the Food and Agriculture Organization have developed a progressive control approach for the management of foot-and-mouth disease (FMD).

It is expected that strict regulations on the sales and use of antibiotics and the high cost of animal health services will inhibit the growth of the European animal health market during the forecast period. For example, the Animal Health Association launched the Antibiotic Commitment in 2017, an antimicrobial resistance (AMR)-related program that aims to promote the responsible use of antibiotics. Such publicity plans and strict regulations have led to a decline in the sales of antimicrobial agents used in veterinary treatment. According to a report issued by the European Medicines Agency (EMA) in October 2018, between 2011 and 2016, the overall sales of veterinary antimicrobials in Europe dropped by 20%.

Do you have specific requirements? Consult our experts: https://www.coherentmarketinsights.com/insight/talk-to-analyst/550

The European Animal Health Market-Impact of the Coronavirus (Covid-19) Pandemic

COVID-19 has had a major impact on the livestock industry. Actions taken by many countries in the world to stop the spread of the coronavirus, such as travel restrictions, national lockdowns, and border controls, have resulted in the following consequences:

Difficulties in transporting live animals and animal products such as milk, meat and eggs

Restrictions and restrictions on the seasonal transit of ruminants

Limited ability to purchase necessary production inputs

Restrict access to labor and professional services

These factors have led to a decline in the sales and processing capacity of animal products and a slowdown in market growth.

Major players operating in the European animal health market include Merck & Co., Inc., Virbac, Dechra Pharmaceuticals Plc., Vetoquinol SA, Zoetis Inc., Ceva Santé Animale, Bayer AG, Elanco, Evonik Industries AG, and Archer Daniels Midland Company .

Reasons for buying this report

• Current status and future prospects of the global European animal health market in developed and emerging markets • Market segments that are expected to dominate the market and the market segment with the highest compound annual growth rate during the forecast period. • Regions/countries that are expected to grow the fastest during the forecast period • The latest developments, market shares and strategies adopted by major market participants

Access research reports tailored for you and your organization to explore practical growth strategies and recommendations

Buy this advanced report at a discounted price @ https://www.coherentmarketinsights.com/insight/buy-now/550

View the press release: https://www.coherentmarketinsights.com/press-release/europe-animal-healthcare-market-3474

Coherent Market Insights is a global market intelligence and consulting organization that provides joint research reports, customized research reports and consulting services. We are known for actionable insights and real reports in various fields such as aerospace and defense, agriculture, food and beverage, automotive, chemicals and materials, and almost all fields and detailed sub-field lists. We create value for customers through highly reliable and accurate reports. We are also committed to playing a leading role in providing insights in various areas after COVID-19 and continue to provide our customers with measurable and sustainable results.

Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154, US Email: sales@coherentmarketinsights.com United States: +1-206-701-6702 United Kingdom: +44-020-8133-4027 Japan: +050 -5539- 1737 India: +91-848-285-0837

Register and submit press release

Medical technology changes the world! Join us to see progress in real time. At Medgadget, we report on the latest technology news, interviews with leaders in the field, and document delivery of medical events around the world since 2004.